Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy

被引:0
|
作者
Mirelis, Jesus G. [1 ,2 ,3 ]
Sanchez-Gonzalez, Javier [1 ,4 ]
Zorio, Esther [5 ]
Ripoll-Vera, Tomas [6 ]
Salguero-Bodes, Rafael [7 ]
Filgueiras-Rama, David [1 ,2 ,8 ]
Gonzalez-Lopez, Esther [1 ,2 ,3 ]
Gallego-Delgado, Maria [1 ,2 ]
Fernandez-Jimenez, Rodrigo [1 ,2 ,9 ]
Jesus Soleto, Maria [6 ]
Nunez, Juana [6 ]
Pizarro, Gonzalo [1 ,2 ,10 ]
Sanz, Javier [9 ]
Fuster, Valentin [1 ,9 ]
Garcia-Pavia, Pablo [1 ,2 ]
Ibanez, Borja [1 ,2 ,11 ]
机构
[1] Inst Salud Carlos III, CNIC, Area Fisiopatol Miocardio, Madrid, Spain
[2] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
[3] Hosp Univ Puerta Hierro, Dept Cardiol, Madrid, Spain
[4] Philips Healthcare, Dept Ciencia Clin, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Dept Cardiol, Valencia, Spain
[6] Hosp Son Llatzer & IdISPa, Dept Cardiol, Palma de Mallorca, Spain
[7] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain
[8] Hosp Univ Clin San Carlos, Dept Cardiol, Madrid, Spain
[9] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Dept Cardiol, New York, NY 10029 USA
[10] Univ Europea Madrid, Complejo Hosp Ruber Juan Bravo, Dept Cardiol, Madrid, Spain
[11] IIS Hosp Fundac Jimenez Diaz, Dept Cardiol, Madrid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2017年 / 70卷 / 11期
关键词
Hypertrophic cardiomyopathy; Computed tomography; Extracellular volume; Diffuse fibrosis; CARDIAC MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 2011 ACCF/AHA GUIDELINE; SUDDEN-DEATH; TASK-FORCE; PROGNOSTIC VALUE; FIBROSIS; PREVALENCE; PREVENTION; DIAGNOSIS;
D O I
10.1016/j.recesp.2017.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Myocardial interstitial fibrosis, a hallmark of hypertrophic cardiomyopathy (HCM), has been proposed as an arrhythmic substrate. Fibrosis is associated with increased extracellular volume (ECV), which can be quantified by computed tomography (CT). We aimed to analyze the association between CT-determined ECV and malignant ventricular arrhythmias. Methods: A retrospective case-control observational study was conducted in HCM patients with implantable cardioverter-defibrillator, undergoing a CT-protocol with continuous iodine contrast infusion to determine equilibrium ECV. Left ventricular septal and lateral CT-determined ECV was compared between prespecified cases (malignant arrhythmia any time before CT scan) and controls (no prior malignant arrhythmias) and among ECV tertiles. Results: A total of 78 implantable cardioverter-defibrillator HCM patients were included; 24 were women, with a mean age of 52.1 +/- 15.6 years. Mean ECV +/- standard deviation in the septal left ventricular wall and was 29.8% +/- 6.3% in cases (n = 24) vs 31.9% +/- 8.5% in controls (n = 54); P=.282. Mean ECV in the lateral wall was 24.5% +/- 6.8% in cases vs 28.2% +/- 7.4% in controls; P=.043. On comparison of the entire population according to septal ECV tertiles, no significant differences were found in the number of patients receiving appropriate shocks. Conversely, we found a trend (P=.056) for a higher number of patients receiving appropriate shocks in the lateral ECV lowest tertile. Conclusions: Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients. (C) 2017 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:933 / 940
页数:8
相关论文
共 50 条
  • [41] Myocardial Fibrosis in Hypertrophic Cardiomyopathy is Associated with Both Left Ventricular and Left Atrial Dysfunction
    Prinz, Christian
    Bitter, Thomas
    Faber, Lothar
    Horstkotte, Dieter
    CIRCULATION, 2011, 124 (21)
  • [42] Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy
    Lu, Dai-Yin
    Yalcin, Hulya
    Yalcin, Fatih
    Zhao, Min
    Sivalokanathan, Sanjay
    Valenta, Ines
    Tahari, Abdel
    Pomper, Martin G.
    Abraham, Theodore P.
    Schindler, Thomas H.
    Abraham, M. Roselle
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (09) : 1081 - 1089
  • [43] Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
    Leonardi, Sergio
    Raineri, Claudia
    De Ferrari, Gaetano M.
    Ghio, Stefano
    Scelsi, Laura
    Pasotti, Michele
    Tagliani, Marilena
    Valentini, Adele
    Dore, Roberto
    Raisaro, Arturo
    Arbustini, Eloisa
    EUROPEAN HEART JOURNAL, 2009, 30 (16) : 2003 - 2010
  • [44] Arrhythmias associated with electroconvulsive therapy in hypertrophic cardiomyopathy
    Adabag, A. Selcuk
    Kim, Helen G.
    Al Aloul, Basel
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (02): : 253 - 255
  • [45] Systolic blood pressure ≤110 mm Hg is associated with severe coronary microvascular ischemia and higher risk for ventricular arrhythmias in hypertrophic cardiomyopathy
    Lu, Dai-Yin
    Yalcin, Hulya
    Yalcin, Fatih
    Sivalokanathan, Sanjay
    V. Greenland, Gabriela
    Ventoulis, Ioannis
    Vakrou, Styliani
    Pampaloni, Miguel Hernandez
    Zimmerman, Stefan L.
    Valenta, Ines
    Schindler, Thomas H.
    Abraham, Theodore P.
    Abraham, Roselle
    HEART RHYTHM O2, 2023, 4 (09): : 538 - 548
  • [46] Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients
    Alsheikh-Ali, Alawi A.
    Link, Mark S.
    Semsarian, Christopher
    Shen, Win-Kuang
    Estes, N. A. Mark, III
    Maron, Martin S.
    Haas, Tammy S.
    Formisano, Francesco
    Boriani, Giuseppe
    Spirito, Paolo
    Maron, Barry J.
    HEART RHYTHM, 2013, 10 (02) : 214 - 218
  • [47] Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis
    Galli, Elena
    Vitel, Emilie
    Schnell, Frederic
    Le Rolle, Virginie
    Hubert, Arnaud
    Lederlin, Mathieu
    Donal, Erwan
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2019, 36 (01): : 74 - 82
  • [48] Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
    Liang, Lusha W.
    Raita, Yoshihiko
    Hasegawa, Kohei
    Fifer, Michael A.
    Maurer, Mathew S.
    Reilly, Muredach P.
    Shimada, Yuichi J.
    HEART, 2022, 108 (22) : 1807 - 1814
  • [49] QRS fragmentation is associated with increased risk of ventricular arrhythmias in high-risk patients; Data from the SMASH 1 Study
    Sourour, Nur
    Riveland, Egil
    Romo, Terje
    Naesgaard, Patrycja
    Kjekshus, Harald
    Larsen, Alf Inge
    Omland, Torbjorn
    Rosjo, Helge
    Myhre, Peder Langeland
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2022, 27 (05)
  • [50] Effects of low-dose amiodarone and Betaloc on the treatment of hypertrophic cardiomyopathy complicated with malignant ventricular arrhythmias
    Gao, Yu
    Zhang, Peisheng
    Liang, Xue
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (02) : 291 - 294